🇮🇳 India Stock Screener ← Switch market ⚡ HerAI

Sagility Limited SAGILITY NIFTY_SMALLNSEPHARMA

Healthcare · Health Information Services · India
https://sagility.com
Company Profile ↓
₹44.41
+2.05% 1Y
Mkt Cap₹20,789.78 Cr
P/E20.95
P/B2.10
Div. Yield0.46%
52W High₹54.40
52W Low₹36.27
Book Value₹20.99
EPS (TTM)₹2.12

Company Overview

Sagility Limited engages in the rendering voice and non-voice business process management and back-office transaction processing services in India, Jamaica, the Philippines, the United States, and Colombia. The company offers claims and membership managed services, such as digital mailroom, product and plan configuration, enrollment and billing, adjudication and adjustment, and appeals management solutions; engagement services; and payer clincal services. It also provides network operations suite comprising provider credentialing, provider data management, provider accuracy, and provider forward solutions; healthcare consulting services; sagility synchrony; healthcare payment integrity services; and provider services that includes patient access, clinical denials management, revenue cycle management, patient engagement, and coding solutions. In addition, the company offers member lifecycle management, provider lifecycle management, claims management, clinical utilization and care management, payment integrity, and provider revenue cycle management solutions. The company was formerly known as Sagility India Limited and changed its name to Sagility Limited in August 2025. Sagility Limited was incorporated in 2021 and is based in Bengaluru, India. The company operates as a subsidiary of Sagility B.V.

Why Investors Should Care

Consistent Profit Growth

Net profit has compounded at 86.1% per year over the last five years.

Steady Revenue Expansion

Revenue has grown at a 19.5% CAGR over the past five years.

Reasonable Valuation

Trades at a P/E of 20.9, below the sector median of 36.4.

Healthy Margins

Operating margin of 15.8% supports profitability.

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.11.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Mar 2026 Revenue of ₹7,192.85 Cr (+29.1% YoY); net profit ₹924.77 Cr.
  • Trailing 12 Months Year-on-year growth — revenue +27.6%, earnings +43.8%.
  • 5-Year Trend Long-term compounding — revenue CAGR 19.5%, profit CAGR 86.1%.

Growth & Price Performance

Compounded Sales Growth

5 Years:19.47%
1 Year:27.60%

Compounded Profit Growth

5 Years:86.06%
1 Year:43.80%

Stock Price Performance

1 Year:+2.05%
6 Months:+5.73%
3 Months:+7.72%
1 Month:-3.35%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 45% of range
₹36.27 ₹54.40
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)50.66 · Neutral
Price Performance
1M-3.35%
3M+7.72%
6M+5.73%
1Y+2.05%
Valuation vs Sector

P/E of 20.95 is below the sector median of 36.43 — relatively cheaper than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 19.5% over 5 years.
  • Profit CAGR of 86.1% over 5 years.
  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
20.95
Industry PE
36.43
Forward P/E
14.79
PEG Ratio
-
Book Value
₹20.99
Price to Book
2.10
P/S
2.70
EV/EBITDA
10.91
Dividend Yield
0.46%

Growth (CAGR)

Revenue 5Y
19.47%
Profit 5Y
86.06%
Revenue (YoY)
27.60%
Earnings (YoY)
43.80%

Profitability & Returns

ROCE
12.50%
ROE
9.57%
ROA
7.34%
Profit Margin
13.04%
Op Margin
15.79%
Gross Margin
37.63%
EPS (Latest Qtr)
₹0.46
EPS (TTM)
₹2.12

Balance Sheet & Liquidity

Debt/Equity
0.11
Quick Ratio
-
Current Ratio
1.55
Debt
₹1,110.53 Cr
Total Assets
₹12,601.08 Cr
Current Assets
₹2,944.54 Cr
Working Capital
₹1,047.04 Cr

Ownership

Promoter Holding
50.95%
Chg in Prom Hold
-0.00%
FII / Inst Holding
23.12%
Chg in FII Hold
-0.00%

Financial Snapshot

Enterprise Value
₹20,789.78 Cr
Total Revenue (TTM)
₹7,617.39 Cr
EBITDA
₹1,891.11 Cr
Free Cash Flow
₹1,010.76 Cr
Operating Cash Flow
₹1,202.97 Cr
Shares Outstanding
₹468.13 Cr
Gross Margin
37.63%
Payout Ratio
2.36%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 SAGILITY Sagility Limited NIFTY_SMALLNSEPHARMA 44.41 20.95 ₹20,789.78 Cr 0.46% 12.50% 9.57% 19.47% 86.06%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,745.10 34.62 ₹4.19 L Cr 0.91% 17.94% 13.74% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 9,190.00 83.58 ₹2.44 L Cr 0.32% 18.96% 15.32% 10.98% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,553.80 72.74 ₹1.73 L Cr 0.81% 9.05% 25.79% 13.27% 20.22%
5 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,117.30 24.90 ₹1.11 L Cr 0.09% 19.04% 18.59% 16.55% 36.99%
6 LENSKART Lenskart Solutions Limited NIFTY_MIDNSEPHARMA 631.35 164.41 ₹1.09 L Cr 0.00% 7.21% 5.65% 35.38% 66.99%
7 APOLLOHOSP Apollo Hospitals Enterprise Limited NIFTY50NSEAIPHARMA 7,600.00 52.32 ₹1.09 L Cr 0.25% 19.20% 20.48% 14.85% 33.34%
8 LAURUSLABS Laurus Labs Limited NIFTY_MIDNSEPHARMA 2,012.50 99.48 ₹1.09 L Cr 0.12% 19.53% 16.77% 3.77% 4.00%
9 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,314.00 31.51 ₹1.06 L Cr 0.99% 14.86% 11.27% 7.23% 11.45%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue 1,116.00 Cr1,094.00 Cr1,260.00 Cr1,283.00 Cr1,223.00 Cr1,325.00 Cr1,453.07 Cr1,568.48 Cr1,538.94 Cr1,658.00 Cr1,971.15 Cr2,024.26 Cr1,963.48 Cr
Cost of Revenue ------862.00 Cr974.10 Cr987.21 Cr-1,219.16 Cr1,276.89 Cr1,227.59 Cr
Gross Profit ------591.07 Cr594.38 Cr551.73 Cr-752.00 Cr747.37 Cr735.89 Cr
Operating Expenses 852.00 Cr860.00 Cr1,000.00 Cr976.00 Cr1,029.00 Cr1,024.00 Cr315.01 Cr335.69 Cr323.83 Cr1,243.00 Cr364.40 Cr386.86 Cr425.76 Cr
Operating Income 98.00 Cr63.00 Cr84.00 Cr131.00 Cr84.00 Cr175.00 Cr276.05 Cr258.69 Cr227.90 Cr293.00 Cr387.59 Cr360.50 Cr310.14 Cr
EBITDA 264.00 Cr234.00 Cr260.00 Cr307.00 Cr194.00 Cr301.00 Cr436.18 Cr383.16 Cr355.98 Cr415.00 Cr486.70 Cr509.44 Cr437.40 Cr
Interest Expense 47.00 Cr48.00 Cr47.00 Cr43.00 Cr37.00 Cr30.00 Cr30.19 Cr29.83 Cr27.41 Cr25.00 Cr24.66 Cr22.10 Cr21.89 Cr
Pretax Income 62.00 Cr43.00 Cr44.00 Cr93.00 Cr71.00 Cr160.00 Cr289.81 Cr238.99 Cr210.39 Cr327.00 Cr338.52 Cr363.18 Cr287.48 Cr
Tax Provision 19.22 Cr8.17 Cr-27.28 Cr13.02 Cr48.99 Cr43.20 Cr72.90 Cr56.41 Cr61.83 Cr75.21 Cr70.86 Cr105.46 Cr70.67 Cr
Net Income 42.00 Cr35.00 Cr71.00 Cr80.00 Cr22.00 Cr117.00 Cr216.91 Cr182.57 Cr148.56 Cr251.00 Cr267.66 Cr257.73 Cr216.81 Cr
Diluted EPS 0.220.180.370.190.050.250.460.390.320.540.570.560.46

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue 923.00 Cr4,218.41 Cr4,753.56 Cr5,569.92 Cr7,192.85 Cr
Cost of Revenue -2,503.01 Cr2,747.00 Cr3,170.32 Cr4,240.11 Cr
Gross Profit -1,715.40 Cr2,006.55 Cr2,399.60 Cr2,952.74 Cr
Operating Expenses 730.00 Cr1,320.35 Cr1,607.67 Cr1,559.46 Cr1,675.38 Cr
Operating Income 46.00 Cr395.05 Cr398.88 Cr840.14 Cr1,277.37 Cr
EBITDA 193.00 Cr1,044.86 Cr1,116.04 Cr1,354.19 Cr1,825.43 Cr
Interest Expense 65.00 Cr214.85 Cr185.15 Cr127.10 Cr99.16 Cr
Pretax Income -2.00 Cr185.68 Cr241.68 Cr760.23 Cr1,238.90 Cr
Tax Provision -3.04 Cr42.10 Cr13.41 Cr221.11 Cr314.13 Cr
Net Income -5.00 Cr143.57 Cr228.27 Cr539.12 Cr924.77 Cr
Diluted EPS -0.020.310.491.171.98

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets -10,590.48 Cr10,664.20 Cr11,050.66 Cr12,601.08 Cr
Current Assets -1,793.42 Cr1,719.92 Cr1,820.77 Cr2,944.54 Cr
Cash & Equivalents -585.29 Cr344.13 Cr343.76 Cr357.92 Cr
Inventory -----
Receivables -637.64 Cr742.16 Cr865.82 Cr1,133.87 Cr
Total Liabilities -4,383.81 Cr4,221.07 Cr2,714.61 Cr2,941.98 Cr
Current Liabilities -1,056.44 Cr1,452.12 Cr1,089.10 Cr1,897.50 Cr
Long Term Debt -2,323.70 Cr1,664.70 Cr567.04 Cr0
Total Debt -2,871.60 Cr2,531.71 Cr1,401.94 Cr1,110.54 Cr
Total Equity -6,206.67 Cr6,443.13 Cr8,336.05 Cr9,659.10 Cr
Shares Outstanding -468.13 Cr468.13 Cr468.13 Cr468.13 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow -32.00 Cr856.78 Cr973.25 Cr1,214.07 Cr1,202.97 Cr
Investing Cash Flow -7,711.00 Cr-129.06 Cr-469.06 Cr-964.21 Cr-710.69 Cr
Financing Cash Flow 8,116.00 Cr-544.62 Cr-751.34 Cr-256.07 Cr-501.40 Cr
Capital Expenditure -7.00 Cr-143.68 Cr-182.73 Cr-124.44 Cr-192.21 Cr
Free Cash Flow -39.00 Cr713.10 Cr790.53 Cr1,089.63 Cr1,010.76 Cr
Net Change in Cash 374.00 Cr183.10 Cr-247.14 Cr-6.21 Cr-9.12 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % -40.7%42.2%43.1%41.1%
Operating Margin % 5.0%9.4%8.4%15.1%17.8%
Net Margin % -0.5%3.4%4.8%9.7%12.9%
ROE % -2.3%3.5%6.5%9.6%
ROCE % -4.1%4.3%8.4%11.9%

Shareholding Pattern

Insiders
50.95%
Institutions
23.12%
Public Float
47.13%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for SAGILITY

Google News hu, 22 Oct 2026

Sagility Q2 FY27 slides: margins hit 6-quarter high at 26.3% - Investing.com Nigeria

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxPTjlMMXFqbWt0ZkF3LUI3d0V1RzRSbkR4ZzE1N3ByY3I0OTduQXB2bm5EalhQejFmUXp3QkVvU09sRGZMUGFFNnhabnJlSmlzSF91ZHk3Qjh2N3RyVTJ5OElBR0JncllSM1YzWU5uZkNGaTJmUUFLaXhFa1ZBYUVvRGctMXV4YUVXa3E5Nm…

Google News hu, 22 Oct 2026

Sagility Limited Approves Interim Dividend for the Financial Year 2026?27, Payable on or Before 21 November 2026 - www.marketscreener.com

<a href="https://news.google.com/rss/articles/CBMi5wFBVV95cUxOODhsVG03RmRfaVRFZ3VJQTFnLUFaRFFVSWVKWktYMVBVNHVVbW02SWZoY2VoZ016QzAtV2pfcDNiMXFrOG43OHNGdmdyV3dhamZTOFUzcFpVVzZOMlpKT0xHSWYtaGU4N0tpRGh5QThyaUpiQ2JzQnhRQWN4SzFtajZZbzNzVk1YZmdmV2…

Google News hu, 22 Oct 2026

Sagility's Chirok Health Acquisition can boost its stock price by 31%, JPMorgan says - CNBC TV18

<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxPekdKRXNEOTVWVmRlZ3EzY3luaUh2RkZoNlJEaHJvYnFjcWNWTElFUzBoNzByQ3h3SWhad0kydlpvVzlONHFHTDNWUjd1OFliS1p3RnBhMkVveXBxU1psNVphRnBFQUlWYlVvbGl2TDlWblhrT3FXLXhreXN2NjZUdzl1NjBPMGVqWEVoMz…

Google News hu, 22 Oct 2026

Stocks To Watch Today: Adani Energy, HPCL, Sagility, Swiggy, Persistent Systems, And More - NDTV Profit

<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxQS3Y1SDJTQk5XQjBtYXVDUUVhWVRzdl9aZkloOVFwMVg1TUJ6eGNxUTlpZnd4Y2NBX0xmMm9ncnFLb2pESzhqZkNVcXFoaTlmYWhhOW9JT01WVFVyTU1Ia2w5VV9uUHFrWXlBTms1N2hSejNpU3hFeTZHdE9fX05FbW1UTVR2d05ZQXdDcj…

Google News hu, 22 Oct 2026

Earnings call transcript: Sagility lifts margin outlook in Q2 2026 By Investing.com - Investing.com UK

<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxNdzNBYVJvWEJLcFFLY3E5TDhoSUtqbXNsSG1odnE1anNSbDVxNDdCV3NVTU1hdVQ5QkpxMVlqQTdOSEE2NGdjc25HYW5nN3l0YjRzUGlmMzYxbkdUamJOTmhrY1ZEZ1E3c056TWxyQkdlU3VBa2dHNDVXM2lJM0UwRG9Jekk3c0FOOU5PYW…

Google News hu, 22 Oct 2026

Sagility - Sobha among 4 stocks closing above VWAP - The Economic Times

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxQaHo4V2RBRHhVNVJ6M1Qxa21iMDFLY2FoWGFOWnhaWEotdG5jZmdoN0I2MHJwVWNtZEVYcGxFSXBnSnZVWmZua3dBVXpBd0lRLXlpY2RFRzhJRGtPS05QTjJOcDUxV1JZdXN3Z1VHb0JmQkNGNXlrajZMandrZkx0V3BRZ21xbGJlb1FUcW…

SAGILITY — Frequently Asked Questions

What is the current share price of Sagility Limited (SAGILITY)?

As of 2026-10-23 04:58 IST, Sagility Limited (SAGILITY) trades at ₹44.41 on NSE. Its 52-week range is ₹36.27 to ₹54.40.

What is the market capitalisation of SAGILITY?

Sagility Limited (SAGILITY) has a market capitalisation of ₹20,789.78 Cr on NSE.

What is the P/E ratio of SAGILITY?

SAGILITY trades at a trailing price-to-earnings (P/E) ratio of 20.95. The industry average P/E is 36.43. Its price-to-book (P/B) ratio is 2.10.

Does SAGILITY pay a dividend?

Sagility Limited (SAGILITY) currently offers a dividend yield of 0.46%.

What is the return on equity (ROE) of SAGILITY?

SAGILITY has a return on equity (ROE) of 9.57%. Its return on capital employed (ROCE) is 12.50%.

Is SAGILITY a good stock to buy?

This page provides a data-driven analysis of Sagility Limited (SAGILITY), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space